Amlodipine Besylate Market by Application and Geography - Forecast and Analysis 2022-2026

The amlodipine besylate market share is expected to increase to USD 217.26 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 3.6%.

The report extensively covers amlodipine besylate market segmentations by the following:

• Application - High blood pressure and heart diseases
• Geography - North America, Europe, Asia, and Rest of World (ROW)

The amlodipine besylate market report offers information on several market vendors, including Amsal Chem Pvt. Ltd., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., CENTURY PHARMACEUTICALS Ltd., Cipla Ltd., Dr. Reddys Laboratories Ltd., MOEHS IBERICA SL, Rakshit Drugs Pvt. Ltd., VPL Chemicals Pvt. Ltd., Changzhou Yabang Pharmaceutical Co. Ltd., Pfizer Inc., Apotex Inc., Lupin Ltd., Strides Pharma Science Ltd, Teva Pharmaceutical Industries Ltd., Chartwell Pharmaceuticals LLC, Synthon International Holding BV, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., and Orbion Pharmaceuticals Pvt. Ltd. among others.

This amlodipine besylate market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches.

What will the Amlodipine Besylate Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Amlodipine Besylate Market Size for the Forecast Period and Other Important Statistics

Amlodipine Besylate Market: Key Drivers, Trends, and Challenges

The rising incidence of hypertension is notably driving the amlodipine besylate market growth, although factors such as side effects on human health may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the amlodipine besylate industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Amlodipine Besylate Market Driver

• The rising incidence of hypertension is one of the key drivers supporting the amlodipine besylate market growth.
• Fundamentally, the effective implementation of guidelines for treating coronary artery disease depends on a number of factors, including the availability of the guidelines and the availability of skilled personnel to carry out their recommendations.
• According to the World Health Organization (WHO), heart disease is one of the most common causes of death in the world, and it is particularly common in low- and middle-income countries.  
• The growth of the amlodipine besylate market is mainly due to the increasing consumption of alcohol, tobacco products, and junk food.
• According to the WHO, it is estimated that 1.13 billion people suffer from hypertension worldwide. Thus, the rising incidence of hypertension will drive the amlodipine besylate market growth during the forecast period.

Key Amlodipine Besylate Market Trend

• Increasing usage of amlodipine besylate in various treatments is one of the key amlodipine besylate market trends contributing to the market growth.
• Amlodipine Besylate is used to treat conditions such as high blood pressure, angina, and coronary heart disease.
• Amlodipine besylate belongs to a class of calcium channel blockers that inhibit the entry of calcium into the slow channels of the myocardium and vascular smooth muscle during depolarization, which causes relaxation of coronary vasodilation and coronary smooth muscle.
• Amlodipine is used to prevent angina, which can be a sign of a heart problem. It may help to increase the ability to exercise and decrease the frequency of angina attacks in high-blood-pressure patients.
• Amlodipine is safe to use during pregnancy and this is likely to fuel the growth of the global amlodipine besylate market during the forecast period.

Key Amlodipine Besylate Market Challenge

• Side effects on human health is one of the factors hampering the amlodipine besylate market growth.
• Amlodipine besylate can cause various side effects to humans including hives, allergic reactions, difficulty breathing, and others.
• Significantly, it is advisable to get medical attention when the symptoms arise such as pounding heartbeats and chest flutters, exacerbation of chest pain, and others.

Thus, such life-threatening side effects may hamper the amlodipine besylate market growth during the forecast period.

This amlodipine besylate market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Who are the Major Amlodipine Besylate Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

• Amsal Chem Pvt. Ltd.
• Aurobindo Pharma Ltd.
• Cadila Pharmaceuticals Ltd.
• CENTURY PHARMACEUTICALS Ltd.
• Cipla Ltd.
• Dr. Reddys Laboratories Ltd.
• MOEHS IBERICA SL
• Rakshit Drugs Pvt. Ltd.
• VPL Chemicals Pvt. Ltd.
• Changzhou Yabang Pharmaceutical Co. Ltd.
• Pfizer Inc.
• Apotex Inc.
• Lupin Ltd.
• Strides Pharma Science Ltd
• Teva Pharmaceutical Industries Ltd.
• Chartwell Pharmaceuticals LLC
• Synthon International Holding BV
• Sun Pharmaceutical Industries Ltd.
• Zydus Lifesciences Ltd.
• Orbion Pharmaceuticals Pvt. Ltd.

This statistical study of the amlodipine besylate market encompasses successful business strategies deployed by the key vendors. The amlodipine besylate market is fragmented and the vendors are deploying growth strategies such as developing cost-effective products, mergers and acquisitions, robust research and development, and geographical expansion to compete in the market.

Product Insights and News

• Amsal.com - The company offers amlodipine besylate used for hypertensive and anginal conditions.
• Cadilapharma.com - The company offers amlodipine besylate tablets which are used for the treatment of hypertension.
• Centurypharma.com - The company offers amlodipine besylate used for hypertensive and anginal condition.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The amlodipine besylate market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Which are the Key Regions for Amlodipine Besylate Market?

For more insights on the market share of various regions Request for a FREE sample now!

39% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for the amlodipine besylate market in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).

Huge investments in the pharmaceutical business will facilitate the amlodipine besylate market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

 In 2020, the outbreak of COVID-19 negatively impacted the regional market. However, in 2021, the initiation of vaccination drives contributed to the containment of the disease. This has eventually led to the lifting of lockdowns and the resumption of all the previously closed public and private business units in the region. Thus, such factors are expected to drive the growth of the amlodipine besylate market during the forecast period.

What are the Revenue-generating Application Segments in the Amlodipine Besylate Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The amlodipine besylate market share growth by the high blood pressure segment will be significant during the forecast period. High blood pressure is a common problem that can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. If not treated, high blood pressure can lead to serious health problems, such as heart attack, heart failure, stroke, kidney failure, and loss of vision. A high blood pressure patient must continue taking amlodipine even if they feel well. Such medication for high blood pressure will drive the amlodipine besylate market growth during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the amlodipine besylate market size and actionable market insights on post COVID-19 impact on each segment.

Parent Market Analysis

Technavio categorizes the amlodipine besylate market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the amlodipine besylate market during the forecast period.

Amlodipine Besylate Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the amlodipine besylate market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Request for a FREE sample

What are the Key Data Covered in this Amlodipine Besylate Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive amlodipine besylate market growth during the next five years
• Precise estimation of the amlodipine besylate market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the amlodipine besylate industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of amlodipine besylate market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch